Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Antibodies in Drug Discovery

Roman Kischel's Biography



Roman Kischel, Principal Scientist, Amgen Research

Roman Kischel is Principal Scientist at Amgen Research (Munich) GmbH, Germany. Roman leads a group developing novel BiTE antibodies specific for different tumor target antigens. Roman has been with Amgen and before the acquisition by Amgen with Micromet for 12 years, working mainly on design and characterization of BiTE antibodies. Previously Roman worked at the Institut für Immunologie at the Ludwig-Maximilians-Universität in Munich. Roman received his M.D. from the Ludwig-Maximilians-Universität.

Roman Kischel Image

CANCELLED DUE TO ILL HEALTH - Targeting Cancer with BiTE® Antibody Constructs

Tuesday, 9 February 2016 at 15:45

Add to Calendar ▼2016-02-09 15:45:002016-02-09 16:45:00Europe/LondonCANCELLED DUE TO ILL HEALTH - Targeting Cancer with BiTE® Antibody ConstructsAntibodies in Drug Discovery in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com

The presentation will demonstrate the structure and mode of action of BiTE® antibody constructs. Clinical and preclinical data for different BiTE® antibody constructs will be discussed.


Add to Calendar ▼2016-02-09 00:00:002016-02-10 00:00:00Europe/LondonAntibodies in Drug DiscoveryAntibodies in Drug Discovery in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com